1.The effect of early higher protein nutrition support and growth hormone in patients with severe craniocerebral injury
Xiaohong XIE ; Jiashi AN ; Yonghua XU
Parenteral & Enteral Nutrition 2004;0(06):-
Objective: To explore the effects of early higher protein nutrition support and growth hormone in patients with severe craniocerebral injury. Methods: 60 patients with severe craniocerebral injury were randomized into observation group and control group.The observation group (30 cases) had received on higher protein nutrition support [2-2.5 g/(kg?d)] and growth hormone for one week. The control group(30 cases) had received lower [1.2-1.5 g/(kg?d) protein nutrition support] for one week. The levels of protein index were determined. The clinical effect and complication were compared between the two groups. Results: The serum prealbumin, albumin, transferrin and hemoglobin in the observation group were significantly higher than those in the control group.The staying time in ICU was significantly shorter and the progrosis was better in the observation group. There were no statistical differences about the index of liver function, renal function and the morbility between the two groups. Conclusion: Early higher protein nutrition support and growth hormone can improve the nutrition status and the prognosis of patients with severe craniocerebral injury.
2.The near future and the forward curative effect of Autologous islet transplantation in the treatment of chronic pancreatitis
Sheng ZHANG ; Yonghua CHEN ; Siming XIE ; Xubao LIU ; Gang MAI
Chinese Journal of Endocrine Surgery 2016;10(6):513-516
Chronic pancreatitis (CP) is a kind of disease with the sustainable and irreversible damage of the tissue structure and function of pancreas,which may be caused by alcohol,gene,gallstone,metabolism,deformity and other factors.The clinical manifestations are intractable abdominal pain and disorder of the internal and external secretion of pancreas.At present,the main purpose of the treatment for chronic pancreatitis is to relieve patients' pain,and to maintain the secretion function of pancreas as far as possible.The main surgical procedures for chronic pancreatitis includes the pancreatic resection,nerve block and decompression drainage of the pancreatic duct.In recent years,people hve paid more attenntion to the whole pancreas resection combined autologous transplantation due to retaining some functions of the islet cells.After whole pancreas resection combined autologous transplantation,the abdominal pain will relieve and the life quality will improved significantly.At the same time,it will effectively reduce the occurrence of pancretogenic diabetes since the surgery retains some function of the islet cells.
3.Diagnosis and treatment of 13 cases of autoimmune pancreatitis
Siming XIE ; Mingliang CHENG ; Yonghua CHEN ; Xubao LIU ; Gang MAI
Journal of Endocrine Surgery 2014;(6):472-474,514
Objective To investigate and summarize the clinical characteristic of autoimmune pancreati-tis(AIP).Methods Clinical data of 13 patients with AIP, admitted to the West China Hospital from 2009 to 2013, were retrospectively analyzed .Results The median age of the 13 patients was 48 years old.The main clinical manifestations included epigastric pain or discomfort (8 cases), obstructive jaundice(7 cases)and weight loss(10 cases).Diffuse enlargement of pancreas and localized pancreatic enlargement were observed in 6 cases, pseudocyst and pancreatic stones were observed in 1 case.Dilation of pancreatic duct was found in 4 cases.Bili-ary stricture and thickened wall of bile duct were detected in 8 cases, dilated gallbladder with delayed enhance-ment of the thickened wall in 7 cases, retroperitoneal fibrosis surrounding the aorta in 1 case, abdominal lymph-adenopathy in 6 cases, stenosis of splenic vein in 4 cases, and Sjogren's disease and ulcerative colitis in 1 case. The positive rate of serum IgG, RF, ANA was 71.43%(5/7), 42.86%(3/7), and 42.86%(3/7), respec-tively.8 patients were misdiagnosed and underwent surgery .Steroid therapy was administered in all patients with satisfactory response.Conclusions AIP is a rare and autoimmune disease ,without speci? c symptoms,and often be misdiagnosed as pancreatic cancer or bile duct carcinoma .We must give more attention to AIP and keep pa-tients from undergoing unnecessary surgery .
4.A study on the pathological type and surgical therapy of chronic pancreatitis
Fazhi ZHAO ; Siming XIE ; Yonghua CHEN ; Yunqiang CAI ; Xing WANG ; Nengwen KE ; Xubao LIU
Chinese Journal of General Surgery 2015;30(1):7-10
Objective To evaluate surgical therapies for chronic pancreatitis.Method The clinical data of 229 patients admitted for chronic pancreatitis during March 2009 to November 2013 in our hospital was retrospectively analyzed,different operation method and their clinical outcome were compared.Results Drainage operations or resection operations were made to all these 229 patients according to different types.57 patients underwent longitudinal pancreaticojejunostomy (LPJ procedure).118 patients received local resection of the head of pancreas combined with longitudinal pancreaticojejunostomy (Frey procedure in 105 cases,Berne procedure in 6 cases,Beger procedure in 7 cases).7 patients received pancreaticoduodenectomy,21 patients received distal pancreas resection,26 patients received other procedures.Post-operative pain relief rate was 89.3%,overall morbidity was 19.6%.Conclusions In cases of chronic pancreatitis,different surgical types are adopted according to their individual indications.Operation in accordance with pathological types guarantees clinical outcome.
5.Effect of Huangxiong Kangshuan capsule on inflammatory factors in patients with acute cerebral infarction
Shijian CAO ; Ni LIU ; Wei HUANG ; Yonghua CHEN ; Yajun LI ; Bo ZHANG ; Tingzhan JIANG ; Daojun XIE
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2017;24(3):246-248
Objective To observe the effect of Huangxiong Kangshuan capsule on serum high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) levels in patients with acute cerebral infarction. Methods Ninety-two patients with acute cerebral infarction admitted to the First Affiliated Hospital of Anhui University of Traditional Chinese Medicinefrom July 2013 to December 2016 were enrolled, and they were divided into an observation group (47 cases) and a control group (45 cases) by random number table. The control group was given conventional treatment of ischemic cerebrovascular disease, while the observation group was additionally treated by Huangxiong Kangshuan capsule orally taken, once 3 tablets, 3 times a day, on the basis of routine treatment; the duration of treatment was 2 weeks in both groups. After 2 weeks of treatment, the clinical effects of the two groups and the changes of serum hs-CRP and IL-6 levels were observed.Results After treatment, the levels of serum hs-CRP and IL-6 were decreased significantly compared with those before treatment in the two groups [observation group: hs-CRP (mg/L) was 6.18±2.17 vs. 14.11±3.01, IL-6 (ng/L): 28.10±11.47 vs. 120.83±24.51; control group: hs-CRP (mg/L) was 8.89±2.46 vs. 13.97±2.69, IL-6 (ng/L) was 49.48±16.43 vs. 115.25±24.05], and the degree of decline in the observation group was more significant than that in the control group [hs-CRP (mg/L): 6.18±2.17 vs. 8.89±2.46, IL-6 (ng/L): 28.10±11.47 vs. 49.48±16.43, bothP < 0.01]; the total effective rate of the observation group was significantly higher than that of the control group [87.2% (41/47) vs. 71.1% (32/45),P < 0.05]. Conclusion Huangxiong Kangshuan capsule can decrease the serum hs-CRP and IL-6 levels in patients with acute cerebral infarction, and has a role in brain protection and nerve function defect improvement.
6.Re-endothelialization after placement of drug-eluting stents in patients with CHD
Minghua LUO ; Huaimin GUAN ; Jinhong XIE ; Yushan CHEN ; He WANG ; Chengjie QIU ; Wenjie DONG ; Yonghua ZONG
The Journal of Practical Medicine 2016;32(5):724-727
Objective To investigate the characteristics of coronary vessel re-endothelialization after placement of drug-eluting stents (DES), and to provide clinical evidence for the double anti-platelet treatment. Methods Optical coherence tomography (OCT) was performed in 43 patients in 1 year after DES implantation. Characteristics of re-endothelialization and percentage of neointimal coverage of stent struts were evaluated by OCT. Results The rate of stent struts intimal coverage was 90.70%, and the remain was lack of endothelial coverage; The ratio of neointimal thickness (NIT) between 0-99, 100-199 and above 200 microns was 19.92%, 37.55% and 42.53%, respectively. The rate of neointimal coverage was higher and the degree of neointimal hy-perplasia was more extensive in patients with DM and in patients with ACS than those of patients without DM and of patients with stable angina pectoris. Conclusion One year after stent placement, most of the stent struts were covered with neointima and few struts obtained poor coverage of endothelial. DM and ACS may be impact factors for the progress of re-endothelialization after DES placement.
8.Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer
Zhe CHEN ; Xiaofeng ZHAI ; Yonghua SU ; Xuying WAN ; Jin LI ; Juemin XIE ; Bo GAO
Journal of Integrative Medicine 2003;1(3):184-6
OBJECTIVE: To observe the clinical effect of cinobufacini injection in treating moderate and advanced primary liver cancer (PLC). METHODS: One hundred patients with moderate and advanced PLC were randomly divided into cino-treated group (50 patients) and control group (50 patients). The quality of life, tumor size, some changes of laboratory tests, and survival time were observed. RESULTS: The progressive rate of cino-treated group (18%) was lower than that of the control group (32%). The quality of life of the cino-treated group (80%) was better than that of the control group (72%), but without statistical significance. The survival rate of >12 months of the cino-treated group (30%) was higher than that of the control group (18%). The patients' liver function such as serum total bilirubin and ALT decreased obviously in the cino-treated group while increased a lot in the control group. The level of AFP increased after treatment with statistical significance in the control group while there was no statistical significance in the cino-treated group. CONCLUSION: Cinobufacini injection can not only inhibit the proliferation of cancer, but also protect liver function, improve quality of life and prolong survival time.
9.Experiment and Pondering of Applying Bilingual Teaching to the Course of Pathology
Xie WANG ; Yingying ZOU ; Zongji ZHANG ; Yonghua RUAN ; Lijuan SHEN ; Jixiao HE
Chinese Journal of Medical Education Research 2003;0(04):-
An experiment of applying bilingual teaching to the course of pathology on the sophomores (students in Grade 2002) was carried out in our department in April 2004. This paper will research the feasibility and necessity of the methodology,ponder the problems in the course of teaching and put forward some suggestions in order to conduct bilingual teaching smoothly on the basis of practice and theory.
10.HPLC separation and determination of bufadienolide in Cinobufacini Injection
Yonghua SU ; Xueqiang HUANG ; Dazhi ZHANG ; Yani ZHANG ; Juemin XIE ; Changquan LING ;
Chinese Traditional Patent Medicine 1992;0(01):-
Objective: To determinate the content of bufalin,resibufogenin and cinobufagin in Cinobufacini Injection. Methods: Liposoluble components in cinobufacini were extracted with ethyl acetate and determined by HPLC using a C 18 column, acetonitrile water(50∶50) as a mobile phase and UV detection wavelength at 299nm. Results: The method showed the good resolution, high sensitivity, satisfactory accuracy and specificity. Quantitatively analyze results showed that the concentration of bufalin, cinobufagin and resibufogenin in Cinobufacini Injection were 0.333 ?g?mL -1 , 0.159?g?mL -1 and 0.110?g?mL -1 , respectively. Conclusion: Bufalin in Cinobufacini Injection reached effective concentration, which was regarded as one of anti cancer components.